Senior insider sale
EVP, Chief Commercial Officer at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$4.87M
9.98K shares
What this filing means
MCKECHNIE DUNCAN plans to sell 9.98K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $4.87M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/11/2026ACC: 0001959173-26-002175
Officer· EVP, Chief Commercial Officer
Since Mar 2026
9.98K
Shares to sell
$4.87M
Approx. market value
2.63K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Restricted Stock Vesting
Compensation
2/17/2026
612.00Restricted Stock Vesting
Compensation
2/10/2026
2.02KTotal acquired2.63K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/17/2026 | Restricted Stock Vesting Compensation | 612.00 | — |
2/10/2026 | Restricted Stock Vesting Compensation | 2.02K | — |
| Total | 2.63K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
2.44K
Market value
$1.16M
3/4/2026
—Completed
Units to sell
4.91K
Market value
$2.39M
2/25/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.63K
Market value
$1.31M
3/11/2026
Total
Units
9.98K
Value
$4.87M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/4/2026 | 2.44K | $1.16M | — | Completed |
2/25/2026 | 4.91K | $2.39M | — | Completed |
| Planned — Approximate Date | ||||
3/11/2026 | 2.63K | $1.31M | NASDAQ | Planned |
| Total | 9.98K | $4.87M | ||